• Applied Strategies with Pazopanib (GW-786034) in Cancer Rese

  2026-05-28

  Pazopanib (GW-786034) empowers researchers to dissect angiogenesis inhibition and tumor growth suppression with unparalleled precision, especially in genetically defined cancer models. From optimized solubility handling to advanced combinatorial workflows, this guide translates bench research into reproducible, high-impact results.

• Calcium’s Modulatory Role in Amyloid Beta Aggregation Reveal

  2026-05-28

  This study introduces supercritical angle Raman and fluorescence spectroscopy to directly investigate how calcium ions modulate amyloid beta aggregation at lipid membranes—an underexplored but crucial mechanism in Alzheimer’s disease. The findings clarify how Ca2+ can both inhibit and exacerbate membrane disruption, depending on the aggregation stage, with practical implications for experimental design and therapeutic targeting.

• ORM2-ZG16 Axis Modulates Pancreatic Fibrosis via Autophagy C

  2026-05-27

  This study establishes that ORM2 alleviates pancreatic fibrosis in chronic pancreatitis by binding to ZG16 and inhibiting autophagy-driven activation of pancreatic stellate cells. The findings clarify a mechanistic pathway regulating fibrogenesis and identify ORM2-ZG16 as a potential molecular target for antifibrotic therapy and pancreatic function research.

• Anlotinib in IADSRCT: Clinical Insights from a Novel TKI App

  2026-05-27

  This article reviews the first documented use of anlotinib hydrochloride—a multi-target tyrosine kinase inhibitor—in treating intra-abdominal desmoplastic small round cell tumor (IADSRCT). The reference case report provides critical evidence for the agent's efficacy in a rare and aggressive sarcoma, highlighting both therapeutic potential and practical considerations for translational cancer research.

• Oral Pathogens Modulate RAS: Surface Proteases Generate Angi

  2026-05-26

  This study reveals that key periodontopathogens, Porphyromonas gingivalis and Tannerella forsythia, can directly degrade angiotensin I to generate Angiotensin (1-7) via unique surface-bound proteases. These findings uncover an oral microbiome-driven axis influencing the renin–angiotensin system, with broad implications for inflammation and systemic disease risk.

• SCH772984 HCl: Precision ERK1/2 Inhibitor for MAPK Pathway R

  2026-05-26

  SCH772984 HCl stands out as a selective ERK1/2 inhibitor, enabling reproducible interrogation of the MAPK signaling pathway in cancer and stem cell models. Its potency, selectivity, and well-characterized workflow advantages make it indispensable for dissecting resistance mechanisms and telomerase regulation.

• NSC 87877: Expanding the Frontier of Shp2 Pathway Inhibition

  2026-05-25

  Explore how NSC 87877, a potent Shp2 inhibitor, enables next-generation research into neuroinflammation, cancer, and pain signaling. This article uniquely bridges structural selectivity, translational workflows, and the latest mechanistic advances.

• H-89 as a cAMP-Dependent Protein Kinase Inhibitor in Osteoge

  2026-05-25

  H-89 enables precise, selective inhibition of PKA to dissect cAMP signaling in bone formation, metabolic regulation, and apoptosis studies. This article details practical workflows, troubleshooting strategies, and recent breakthroughs—highlighting how H-89 empowers high-confidence research in cellular signaling.

• Genetic Tracing Refutes Postnatal Neo-oogenesis in Mouse Ova

  2026-05-24

  Xie et al. introduce a dual recombinase-mediated genetic tracing system to rigorously test the longstanding hypothesis of postnatal neo-oogenesis in mice. Their findings provide robust evidence that adult female mice do not regenerate oocytes in vivo, even after germ cell depletion, challenging previous notions and refining experimental approaches in ovarian biology.

• 5-Methyl-CTP in mRNA Synthesis: Precision Tools for Personal

  2026-05-23

  Explore how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, empowers next-gen mRNA synthesis for personalized vaccines. This article uniquely dissects mechanistic advances and translational assay design beyond current reviews.

• Dual-Action Inhibition Drives p38α MAPK Dephosphorylation Pr

  2026-05-22

  The referenced study reveals how select kinase inhibitors, including indole-5-carboxamide derivatives, not only block the p38α MAPK active site but also promote its dephosphorylation by stabilizing a conformation favored by phosphatases. This dual-action mechanism offers a new strategy for achieving specificity and potency in targeting kinase-driven disease pathways, with implications for inflammation, cell differentiation, and type 1 diabetes research.

• Anlotinib Hydrochloride: A New Paradigm in Angiogenesis Rese

  2026-05-22

  This in-depth article explores the mechanistic foundation, translational potential, and strategic workflow integration of Anlotinib hydrochloride as a multi-target tyrosine kinase inhibitor. Blending peer-reviewed clinical insight with experimental guidance, it equips cancer and vascular biology researchers to harness this advanced reagent for reproducible, high-content studies on tumor angiogenesis and endothelial dynamics.

• Norovirus Utilizes NINJ1 for Selective Protein Secretion via

  2026-05-21

  This study uncovers how murine norovirus co-opts the plasma membrane rupture protein NINJ1 to selectively secrete its NS1 protein through a caspase-3–dependent, unconventional pathway. The findings provide mechanistic insight into viral immune evasion and regulated DAMP release, with broad implications for understanding host-pathogen interactions in cell death.

• Praeruptorin A: Molecular Precision in Ferroptosis and Infla

  2026-05-21

  Explore the advanced molecular mechanisms of Praeruptorin A, an angular pyranocoumarin compound, in ferroptosis inhibition and anti-inflammatory pathways. This article uniquely bridges mechanistic insights with practical assay decisions for translational research.

• MEK1/2-ERK1/2 Pathway Drives Alveolar Hemorrhage in Lupus Mo

  2026-05-20

  This study demonstrates that MEK1/2-ERK1/2 activation underlies diffuse alveolar hemorrhage (DAH) in a murine model of lupus, with pharmacological inhibition by Trametinib (GSK1120212) preventing endothelial injury and restoring hemostasis. The findings clarify the molecular drivers of DAH and offer an experimental framework for dissecting MAPK pathway contributions in autoimmune lung injury.

15870 records 1/1058 page Next 12345 下5页 Last page